Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ebru Aydin
Institutions:
German Cancer Research Center,
University of Gothenburg
Observed institutions:
Uppsala University,
German Cancer Research Center,
Hammersmith Hospital,
Tesaro (United States),
Imperial College London,
University of Gothenburg
show all 6
ORCID:
0000-0003-2395-7529
Observed ORCID:
0000-0003-2395-7529
OpenAlex ID:
A5007258281
Role of NOX2-Derived Reactive Oxygen Species in NK Cell–Mediated Control of Murine Melanoma Metastasis
2017
·
Ebru Aydin
, Junko Johansson
, et al.
·
Cancer Immunology Research
·
126
NOX2 in autoimmunity, tumor growth and metastasis
2018
·
Anna Martner
, Ebru Aydin
, et al.
·
The Journal of Pathology
·
84
PDF
NOX2-Derived Reactive Oxygen Species in Cancer
2020
·
Hanna Grauers Wiktorin
, Ebru Aydin
, et al.
·
Oxidative Medicine and Cellular Longevity
·
66
PDF
Increased risk of brain metastases in ovarian cancer patients with BRCA mutations
2019
·
Elena Ratner
, Mohan Bala
, et al.
·
Gynecologic Oncology
·
56
Histamine Promotes the Development of Monocyte-Derived Dendritic Cells and Reduces Tumor Growth by Targeting the Myeloid NADPH Oxidase
2015
·
Anna Martner
, Hanna G Wiktorin
, et al.
·
The Journal of Immunology
·
45
PDF
NOX2 inhibition reduces oxidative stress and prolongs survival in murine KRAS-induced myeloproliferative disease
2018
·
Ebru Aydin
, Alexander Hallner
, et al.
·
Oncogene
·
42
PDF
Sirtuin1 (SIRT1) in the Acetylation of Downstream Target Proteins
2016
·
Ana R. Gomes
, Jay Sze Yong
, et al.
·
Methods in molecular biology
·
32
Anti-Leukemic Properties of Histamine in Monocytic Leukemia: The Role of NOX2
2018
·
Roberta Kiffin
, Hanna Grauers Wiktorin
, et al.
·
Frontiers in Oncology
·
29
PDF
Phosphoinositide 3-Kinase Signaling in the Tumor Microenvironment: What Do We Need to Consider When Treating Chronic Lymphocytic Leukemia With PI3K Inhibitors?
2021
·
Ebru Aydin
, Sebastian Faehling
, et al.
·
Frontiers in Immunology
·
27
PDF
Impact of IL-1β and the IL-1R antagonist on relapse risk and survival in AML patients undergoing immunotherapy for remission maintenance
2021
·
Hanna Grauers Wiktorin
, Ebru Aydin
, et al.
·
OncoImmunology
·
25
PDF
Idelalisib Rescues Natural Killer Cells from Monocyte-Induced Immunosuppression by Inhibiting NOX2-Derived Reactive Oxygen Species
2020
·
Ali A. Akhiani
, Alexander Hallner
, et al.
·
Cancer Immunology Research
·
21
Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer
2024
·
Hanna Grauers Wiktorin
, Ebru Aydin
, et al.
·
Cancer Research Communications
·
19
PDF
Role of NOX2 for leukaemic expansion in a murine model of BCR‐ABL1+ leukaemia
2017
·
Hanna Grauers Wiktorin
, Tina Nilsson
, et al.
·
British Journal of Haematology
·
13
A hypomorphic Cbx3 allele causes prenatal growth restriction and perinatal energy homeostasis defects
2015
·
Ebru Aydin
, Dick-Paul Kloos
, et al.
·
Journal of Biosciences
·
12
PDF
mRNA-Binding Protein TIA-1 Reduces Cytokine Expression in Human Endometrial Stromal Cells and Is Down-Regulated in Ectopic Endometrium
2014
·
Hakan Mete Karalok
, Ebru Aydin
, et al.
·
The Journal of Clinical Endocrinology & Metabolism
·
12
Isolated limb perfusion with melphalan activates interferon-stimulated genes to induce tumor regression in patients with melanoma in-transit metastasis
2019
·
Junko Johansson
, Roberta Kiffin
, et al.
·
OncoImmunology
·
10
Cytomegalovirus Serostatus Affects Autoreactive NK Cells and Outcomes of IL2-Based Immunotherapy in Acute Myeloid Leukemia
2018
·
Elin Bernson
, Alexander Hallner
, et al.
·
Cancer Immunology Research
·
9
Real-world data analysis of ovarian cancer (OC) maintenance utilization among maintenance eligible patients.
2019
·
David Garofalo
, Ebru Aydin
, et al.
·
Journal of Clinical Oncology
·
8
Recurrence of ovarian cancer in BRCAwt patients without maintenance therapy: Real-world evidence.
2019
·
Melinda Louie-Gao
, Ebru Aydin
, et al.
·
Journal of Clinical Oncology
·
2
FIGURE 2 from Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer
2024
·
Hanna Grauers Wiktorin
, Ebru Aydin
, et al.
Figure S3 from Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer
2024
·
Hanna Grauers Wiktorin
, Ebru Aydin
, et al.
FIGURE 2 from Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer
2024
·
Hanna Grauers Wiktorin
, Ebru Aydin
, et al.
TABLE 1 from Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer
2024
·
Hanna Grauers Wiktorin
, Ebru Aydin
, et al.
FIGURE 5 from Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer
2024
·
Hanna Grauers Wiktorin
, Ebru Aydin
, et al.
Figure S4 from Impact of Surgery-Induced Myeloid-derived Suppressor Cells and the NOX2/ROS Axis on Postoperative Survival in Human Pancreatic Cancer
2024
·
Hanna Grauers Wiktorin
, Ebru Aydin
, et al.
Show more works
View as search
Works count:
55
Citation count:
638
H-index:
13
I10-index:
16
Year
Topic
Type